Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: Pathological synergy of Alzheimer's disease and diabetes mellitus

Tony Valente, Alejandro Gella, Montse Solé, Núria Durany, Mercedes Unzeta

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1) is involved in vascular endothelial damage as well as in the vascular degeneration underlying diabetes mellitus and Alzheimer's disease (AD). Recent evidence suggests that classic pathological features of AD are more pronounced in diabetic mellitus patients. To investigate the expression and distribution of SSAO/VAP-1 in the two pathologies, we have performed an immunohistochemical study in human hippocampal vessels of AD, AD with diabetic mellitus (ADD), diabetic mellitus (DM), and nondemented (ND) patients. The present results demonstrate major vessel accumulation of both SSAO/VAP-1 and amyloid-β immunolabeling intensity in ADD compared with AD patients. Interestingly, nearly damaged vessels with high levels of SSAO/VAP-1 also showed increased oxidative damage markers (AGE, RAGE, and SOD-1) and glial activation (GFAP and HLA). Overall, this work suggests that high vascular SSAO/VAP-1 levels in human hippocampus may contribute to vascular degeneration, which can explain the severe progression in patients with both pathologies. © 2012 Wiley Periodicals, Inc..
Original languageEnglish
Pages (from-to)1989-1996
JournalJournal of Neuroscience Research
Volume90
DOIs
Publication statusPublished - 1 Oct 2012

Keywords

  • Advanced glycation end products
  • Alzheimer's disease
  • Amyloid-β
  • Cerebral blood vessels
  • Diabetes mellitus
  • Immunohistochemistry
  • SSAO/VAP-1

Fingerprint Dive into the research topics of 'Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: Pathological synergy of Alzheimer's disease and diabetes mellitus'. Together they form a unique fingerprint.

Cite this